14:03:31 EST Sun 03 Mar 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:AWKN from 2023-03-02 to 2024-03-01 - 39 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-02-13 15:41C:AWKNAwakn Life Sciences Corp0.115News ReleaseAwakn Life Sciences begins trading on CSE
2024-02-12 10:51C:AWKNAwakn Life Sciences Corp0.14News ReleaseAwakn Life to begin trading on CSE Feb. 13
2024-02-09 23:07C:AWKNAwakn Life Sciences Corp0.14MiscellaneousAwakn Life to be delisted from Cboe Canada
2024-02-09 22:16C:AWKNAwakn Life Sciences Corp0.14New ListingAwakn Life to trade on CSE Feb. 13
2024-02-05 16:59C:AWKNAwakn Life Sciences Corp0.14MiscellaneousAwakn Life delisting review extended
2024-02-05 10:59C:AWKNAwakn Life Sciences Corp0.12News ReleaseAwakn to list on CSE, closes $65,714 financing tranche
2024-01-24 11:19C:AWKNAwakn Life Sciences Corp0.11News ReleaseAwakn Life completes investigate study on S-ketamine
2023-12-20 10:27C:AWKNAwakn Life Sciences Corp0.145News ReleaseAwakn licenses S-ketamine formulation from LTS
2023-12-15 10:44C:AWKNAwakn Life Sciences Corp0.135News ReleaseAwakn closes $230,000 fourth tranche of financing
2023-12-14 15:13C:AWKNAwakn Life Sciences Corp0.135SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-12-14 15:13C:AWKNAwakn Life Sciences Corp0.135SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-15 10:35C:AWKNAwakn Life Sciences Corp0.065News ReleaseAwakn receives approvals for phase III AWKN-P001 trial
2023-11-10 17:24C:AWKNAwakn Life Sciences Corp0.21MiscellaneousAwakn Life under Neo delisting review
2023-11-10 17:18C:AWKNAwakn Life Sciences Corp0.21News ReleaseAwakn Life not compliant with Cboe listing rules
2023-10-31 12:38C:AWKNAwakn Life Sciences Corp0.24News ReleaseAwakn Life hires Orphan Insight for AWKN-P001 work
2023-10-04 11:01C:AWKNAwakn Life Sciences Corp0.24News ReleaseAwakn Life completes Zydis ODT feasibility study
2023-09-14 12:51C:AWKNAwakn Life Sciences Corp0.255News ReleaseAwakn closes $767,215 third tranche of financing
2023-09-14 07:23C:AWKNAwakn Life Sciences Corp0.245SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-09-14 07:23C:AWKNAwakn Life Sciences Corp0.245SEDAR Interim MD & ASEDAR Interim MD & A
2023-09-06 10:46C:AWKNAwakn Life Sciences Corp0.27News ReleaseAwakn submits application for phase III AWKN-P001 trial
2023-08-01 15:20C:AWKNAwakn Life Sciences Corp0.26News ReleaseAwakn Life Sciences sells clinics in Norway
2023-07-05 12:38C:AWKNAwakn Life Sciences Corp0.235News ReleaseAwakn completes Awakn Clinics London sale
2023-06-27 17:22C:AWKNAwakn Life Sciences Corp0.21News ReleaseAwakn Life shareholders approve AGM resolutions
2023-06-15 13:12C:AWKNAwakn Life Sciences Corp0.20News ReleaseAwakn closes second tranche, upsizes financing to $4M
2023-06-14 18:04C:AWKNAwakn Life Sciences Corp0.20SEDAR MD & ASEDAR MD & A
2023-06-14 18:03C:AWKNAwakn Life Sciences Corp0.20SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-06-09 12:16C:AWKNAwakn Life Sciences Corp0.245News ReleaseAwakn to exit health care services, focus on R&D
2023-06-09 12:16C:AWKNAwakn Life Sciences Corp0.25Resume TradingAwakn Life Sciences to resume at 9:30 a.m. PT
2023-06-09 09:09C:AWKNAwakn Life Sciences Corp0.25Halt TradingAwakn Life Sciences halted at the open
2023-04-28 08:31C:AWKNAwakn Life Sciences Corp0.30News ReleaseAwakn brags about 2023 sales but stays hush on P&L
2023-04-27 17:10C:AWKNAwakn Life Sciences Corp0.30SEDAR Annual Information FormSEDAR Annual Information Form
2023-04-27 17:08C:AWKNAwakn Life Sciences Corp0.30SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-04-27 17:06C:AWKNAwakn Life Sciences Corp0.30SEDAR MD & ASEDAR MD & A
2023-04-26 09:15C:AWKNAwakn Life Sciences Corp0.23News ReleaseAwakn arranges $3M financing, closes first tranche
2023-04-26 09:01C:AWKNAwakn Life Sciences Corp0.23Resume TradingAwakn Life Sciences resuming at the open
2023-04-26 08:08C:AWKNAwakn Life Sciences Corp0.23Halt TradingAwakn Life Sciences halted at the open
2023-04-18 13:24C:AWKNAwakn Life Sciences Corp0.24News ReleaseAwakn, UoE sign collaboration deal for phase III trial
2023-04-12 10:13C:AWKNAwakn Life Sciences Corp0.23News ReleaseAwakn's Sessa resigns as head of psychedelic medicine
2023-03-02 15:32C:AWKNAwakn Life Sciences Corp0.39News ReleasePharmala Biotech to supply MDMA to Awakn